2025-00106Notice

Secret Disease Meeting Announced With Zero Details Given

Published Date: 1/7/2025

Notice

Summary

The National Institute of Allergy and Infectious Diseases is holding a private meeting from January 27-29, 2025, to review secret contract proposals for new tests to detect Mycoplasma genitalium infections. This affects researchers and companies competing for funding to develop these diagnostics. The meeting keeps sensitive info safe and helps decide who gets money to fight infections.

Analyzed Economic Effects

2 provisions identified: 2 benefits, 0 costs, 0 mixed.

Closed review to protect trade secrets

The meeting is closed to the public under 5 U.S.C. sections 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, patentable commercial material, and personal information. This preserves privacy and proprietary details for companies and researchers whose contract proposals are discussed.

Proposals reviewed for Mycoplasma genitalium diagnostics

The National Institute of Allergy and Infectious Diseases will review and evaluate contract proposals for 'Development of Diagnostics for Mycoplasma genitalium Infection (Topic 143)' on January 27-29, 2025, from 9:00 a.m. to 1:00 p.m. This affects researchers and companies that submitted proposals on that topic because their submissions will be evaluated at that meeting.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
Effective Date
1/7/2025
1/27/2025

Department and Agencies

Department
Independent Agency
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register